PACB Pacific Biosciences of California
Company Analysis
Latest News
🔴 Pacific Biosciences is trading 6.7% down today amid biotech-sector weakness
Pacific Biosciences is trading at $2.68, down 6.69%, with biotech-sector weakness a possible contributor. - The XBI is down 2.50%, while major U.S. indices...
PacBio Rides a Rare-Disease Partnership Wave to New Highs — But Can a Sub-$900M Company Turn Ecosystem Wins Into Revenue?
Shares shifted sharply as Pacific Biosciences (PACB) extended a blistering October rally, trading at $3.07 — up 7% on the day and 68% from just a week ago at...
🟢 Pacific Biosciences is trading 16% up today after EpiSign-Geneyx rare-disease partnership
Pacific Biosciences is trading 16.20% higher at $3.33 following news of an EpiSign and Geneyx partnership to bring PacBio HiFi sequencing data into...
🟢 Pacific Biosciences is trading 7% up today after EpiSign–Geneyx rare-disease partnership
Pacific Biosciences is trading at $3.07, up +7.04%, as an EpiSign–Geneyx partnership uses PacBio HiFi data for rare-disease interpretation. - The agreement...
🟢 Pacific Biosciences is trading 10% up today amid broader-market gains
Pacific Biosciences is trading at $2.79, up +10.04%, amid broader-market support; no clear new company-specific trigger was identified. - Its press-release...
🟢 Pacific Biosciences is trading 5% up
Pacific Biosciences is trading at $2.67, up 5.12% on October 5, 2026, with no clear company-specific catalyst identified. - The October 1 surge was attributed...
🟢 Pacific Biosciences is trading 5% up; no clear catalyst identified
Pacific Biosciences is trading 5.27% up at $2.50 on October 1, extending a multi-session rally with no clearly established catalyst for the latest increase. -...
🟢 Pacific Biosciences is trading 12.57% up — no clear September 30 catalyst identified
Pacific Biosciences is trading at $2.06, up 12.57%, with no clear September 30 catalyst identified. - A contemporaneous market report also described the move...
🟢 Pacific Biosciences is trading 7.65% up; no September 30 catalyst identified
Pacific Biosciences is trading up 7.65% at $1.97 on September 30, 2026; no new company announcement or clear catalyst specific to the session was...
🟢 Pacific Biosciences is trading 5.7% up; no clear catalyst identified
Pacific Biosciences is trading 5.7% higher at $1.81 on September 29, 2026, with no new company-specific announcement identified to explain the move. - A...
🟢 Pacific Biosciences is trading 10.2% up
Pacific Biosciences is trading at $1.78, up 10.19%, with no clear company-specific catalyst identified for the September 28, 2026 rise. - Recent coverage of...
🟢 Pacific Biosciences is trading 7.1% up with no clear company-specific catalyst identified
Pacific Biosciences is trading at $1.74, up 7.10%, with no clear company-specific explanation for its September 28 rise identified in the search. - Recent...
🟢 Pacific Biosciences is trading 10.6% up today with no clear catalyst identified
Pacific Biosciences is trading 10.64% higher at $1.56, with no clear company-specific catalyst identified for September 24, 2026. - The biotechnology sector is...
🟢 Pacific Biosciences is trading 6% up today with no identified catalyst
Pacific Biosciences is trading 6.03% higher at $1.50, with no confirmed catalyst identified. - No September 24, 2026 earnings, regulatory, partnership,...
🔴 Pacific Biosciences is trading 5% down today amid rising yields and biotech-sector losses
Pacific Biosciences is trading at $1.40, down 5.10%, as broad risk-off pressure weighs on growth-oriented biotech stocks. - Rising crude oil and Treasury...
🟢 Pacific Biosciences is trading 5.9% up today amid sector-driven biotech strength
Pacific Biosciences is trading 5.9% up at $1.44, apparently on sector-driven biotech and technology strength. - The Nasdaq Biotechnology Index rose 1.10% on...
🟢 Pacific Biosciences rises 5.6% — Biotech Sector Rallies on Strong Industry Outlook and M&A Optimism
With Biotech (XBI) up 2.5%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector, as measured by the XBI ETF,...
🟢 Pacific Biosciences is trading 5% up today with no clear company-specific catalyst
Pacific Biosciences is trading $1.37, up 5.32%, with no clear company-specific announcement explaining the September 14, 2026 move. - Management is scheduled...
🔴 Pacific Biosciences is trading 5.2% down today amid risk-off sentiment from Middle East tensions
Pacific Biosciences is trading 5.2% down at $1.28 as the broader market and biotechnology sector weaken. - On September 1, 2026, risk-off sentiment reflects...
🔴 Pacific Biosciences falls 5.2% — Biotech Sector Declines Amid Fed Rate Hike Fears
With Biotech (XBI) down 2.3%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, as measured by the XBI ETF, fell...